The IMID Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Latest episodes
Dec 9, 2021 • 39min
Insights at ACR 2021: Impact of COVID-19 on Practice
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 7, 2021 • 40min
Insights at ACR 2021: COVID Vaccinations
Gain insight into the latest research presented at ACR 2021. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors.
Dec 6, 2021 • 24min
Author Interview: Professor Atul Deodhar
Professor Atul Deodhar, professor of medicine at Oregon Health & Science University.
Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Atul Deodhar discusses his review on JAK-STAT signalling in spondyloarthritis and what that means for the use of JAK inhibitors for SpA treatment.
Dec 6, 2021 • 8min
Discussing Rheumatology: Risk of HZ with UPA, and JAKs in SpA
Prof Iain McInnes reviews two papers this month, and discusses the increased risk of HZ infection with upadacitinib, as well as the role of the JAK-STAT pathway in SpA pathenogenesis. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
Nov 18, 2021 • 29min
Author Interview: Professor Roy Fleischmann
Professor Roy Fleishmann, clinical professor of medicine at the University of Texas Southwestern Medical Center.
Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Professor Roy Fleishmann discusses the effect of baricitinib on inhibiting radiographic progression of structural joint damage over 5 years in patients with active RA.
Nov 9, 2021 • 26min
ACR 2021: Day 4 Highlights
Grace Wright presents the Day 4 highlights of the key abstracts and posters presented at ACR 2021.
Nov 8, 2021 • 22min
ACR 2021: Day 3 Highlights
Professor Leonard Calabrese presents the Day 3 highlights of the key abstracts and posters presented at ACR 2021.
Nov 7, 2021 • 23min
ACR 2021: Day 2 Highlights
Grace Wright presents the Day 2 highlights of the key abstracts and posters presented at ACR 2021.
Nov 4, 2021 • 8min
Discussing Rheumatology: Herpes Zoster and HBV
Prof Iain McInnes discusses the risk of herpes zoster in RA patients taking biologics and DMARDS. He also discusses reactivation of hepatitis B in patients with RA taking tofacitinib. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
Nov 4, 2021 • 11min
ACR 2021: Day 1 Highlights
Prof Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2021.
